1. Home
  2. XBP vs CVM Comparison

XBP vs CVM Comparison

Compare XBP & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

HOLD

Current Price

$2.94

Market Cap

24.4M

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.22

Market Cap

20.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
CVM
Founded
N/A
1983
Country
United States
United States
Employees
10200
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
20.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
XBP
CVM
Price
$2.94
$1.22
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
24.0K
363.4K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$0.41
$0.89
52 Week High
$8.55
$13.48

Technical Indicators

Market Signals
Indicator
XBP
CVM
Relative Strength Index (RSI) 65.45 42.61
Support Level $3.31 $0.95
Resistance Level $4.80 $1.46
Average True Range (ATR) 0.37 0.12
MACD 0.10 0.01
Stochastic Oscillator 72.36 19.44

Price Performance

Historical Comparison
XBP
CVM

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: